SLC4A7 and neoplasm: Recently, a number of labs have begun targeting bicarbonate transporters because they are upregulated in multiple cancer types, where they promote tumor cell growth, survival, and immunosuppression (Cappellesso et al, 2022; McIntyre et al, 2016; Pollay et al, 1985).